Aurinia Pharmaceuticals (AUPH) Deferred Taxes (2026)
Aurinia Pharmaceuticals' Deferred Taxes came in at $11.11 million for Q2 2026, up 19.8% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Deferred Taxes (2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aurinia Pharmaceuticals reported Deferred Taxes of $20.39 million; for FY2025, it came in at -$176.19 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -398.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.20 Bn | 623.91 Mn | 76.67 Mn | 11.11 Mn |
API Access
Aurinia Pharmaceuticals Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();